Evaluation of safety and efficacy of tenofovir disoproxil in hemodialysis and renal transplant patients monoinfected with hepatitis B virus based on real life data.

Akyüz F., Çavuş B., Nizam N., Göktürk S., Baran B., Yazıcı H., ...Daha Fazla

Clinical and experimental hepatology, cilt.8, sa.1, ss.7-13, 2022 (Hakemli Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 8 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.5114/ceh.2022.114153
  • Dergi Adı: Clinical and experimental hepatology
  • Sayfa Sayıları: ss.7-13
  • Anahtar Kelimeler: safety, tenofovir, renal transplantation, hemodialysis, chronic hepatitis B, FUMARATE, ALAFENAMIDE, PHARMACOKINETICS, DYSFUNCTION, THERAPY
  • İstanbul Üniversitesi Adresli: Evet

Özet

Introduction: There are limited data about the safety of tenofovir disoproxil fumarate (TDF) in chronic renal failure (CRF). In this study, we aimed to evaluate the safety and efficacy of TDF in renal transplant recipients and hemodialysis patients with chronic hepatitis B (CHB) during long-term follow-up.